Skip 
Navigation Link
Medical Disorders
Resources
Basic InformationLookupsLatest News
Excess Weight May Raise Rosacea RiskDecline in Antibiotic Use in Livestock Isn't Enough, Critics SayCould a Hot Cup of Tea Preserve Your Vision?Breathing Retraining Beneficial in Patients With AsthmaZika Babies Facing Increasing Health Problems With AgeHealth Tip: Dental Association Supports Fluoridated WaterAnother Legacy of Terror Attacks: MigrainesRain May Not Cause Achy Joints After AllDisrupted Sleep Linked to Increased Amyloid-β ProductionAtherosclerosis ID'd in Many Without CV Risk FactorsArtificial Intelligence Promising for CA, Retinopathy DiagnosesFirst Drug Approved for Rare Condition That Inflames Blood VesselsProtecting Your Health From Wildfire SmokeHealth Tip: Recognize Warning Signs of HypothermiaNew Hope for Kids With Multiple Food AllergiesFew Patients, Providers Discuss Costs of Glaucoma Medicationsβ-Cell Sensitivity to Glucose Impaired After Gastric BypassHow to Perk Up the Holidays for Hospital PatientsVigorous Exercise May Help Slow Parkinson's DiseaseIf Mom Has Rheumatoid Arthritis, Baby May Develop It, TooNew Gene Therapy May Be Cure for 'Bubble Boy' DiseaseAnother Gene Therapy Breakthrough Against HemophiliaPrenatal Sugar Intake May Increase Asthma Risk in OffspringObesity May Be Tied to Higher Rosacea Risk in WomenGot Scabies? Here's What to DoAre Women With Parkinson's at a Disadvantage?Bariatric Surgery Alters Liver Fatty Acid MetabolismORBIT Bleeding Risk Score Performs Best in A-FibHealth Tip: Prevent the Spread of NorovirusAre Good Kidneys Going to Waste?Metabolic Risk Factors Linked to Severe Liver DiseaseImpaired White Matter Integrity for Depression in Parkinson'sHave Eczema? No Need for Bleach Baths, Study SuggestsPowerful Clot-Busting Drugs Not Useful After Leg Blockages: StudyComing Soon: A Gel That Could Help Save Soldiers' EyesGene Therapy May Allow Hemophilia Patients to Go Without MedsThyroidectomy-Specific Quality Improvement Measures ID'dPatients OK With Fewer Opioids After Gallbladder SurgeryShhhh! Patients Are SleepingDiagnostic Mutations ID'd in Chronic Kidney Disease PatientsAntithrombotics Deemed Safe in Carpal Tunnel Release SurgeryLink Between Diabetes, Antibiotic Use Called Into QuestionHealth Tip: Diagnosing PneumoniaNoisy Commutes Could Cause Long-Lasting DamageThe Buzz on How Flies Spread DiseaseRisk of Surgical Complications Up for Overlapping Hip SurgeryOral Microbiome Composition Linked to Esophageal Cancer RiskSmartphone Pics Help Docs ID Kids' Skin ConditionEven Non-Heart Surgery May Harm Your HeartCan Scrotal Vein Condition Hike Heart Risks?
Questions and AnswersLinksBook Reviews
Related Topics

'Good' Donor Bacteria Can Last Long Term in Stool Transplant Patients

HealthDay News
by -- Robert Preidt
Updated: Jun 16th 2017

new article illustration

FRIDAY, June 16, 2017 (HealthDay News) -- Researchers say their small study offers the first proof that therapeutic donor microbes remain for months or years in patients who've undergone stool transplants.

Medically known as "fecal microbiota transplantation" (FMT), the procedure is used to treat severe diarrhea and colitis caused by repeated Clostridium difficile infections, the researchers explained.

FMT is an increasingly popular treatment for C. difficile infections, with a 90 percent success rate. It involves collecting stool from a healthy donor and mixing it with salt water. The solution is then transferred to the patient's digestive tract through a thin, flexible tube called a colonoscope, or through the nose.

C. difficile gut infections can be deadly. They often follow use of antibiotics that change the normal balance of bacteria in a patient's gut. C. difficile is increasingly resistant to standard antibiotic treatments.

The aim of a fecal transplant is to restore beneficial gut bacteria. A balance of good and bad bacteria makes it easier to fight infection.

The study included seven patients. In two, some donor microbe strains persisted as long as two years after a transplant. In five others, donor strains persisted for three to six months, according to the University of Alabama at Birmingham researchers.

They were led by Ranjit Kumar, a biomedical informatics specialist.

"The demonstration that certain transplanted microbes can persist for up to two years demonstrates the potential of using FMT for long-term changes in the composition of the gastrointestinal tract microbe communities," the researchers wrote.

They said the results offer insights "that are essential for development of new approaches to improve health via manipulation of this complex microbial community."

The Alabama researchers added that the method they used to zero in on specific strains of gut bacteria for their study may help warn of changes related to illnesses like diabetes, obesity, ulcerative colitis or Parkinson's disease.

"This early warning system could be used to signal the use of interventions, such as microbe transplants, designed to maintain the gut microbe community structure necessary for efficient metabolic function needed for human health," said study co-author Casey Morrow, retired professor of cell, developmental and integrative biology.

The study was published online recently in the journal Biofilms and Microbiomes.

More information

For more on FMT, go to the Fecal Transplant Foundation.